Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

2.2K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

2.8K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.8K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

432
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
432
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

277
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
277
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

473
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
473
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.7K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibiotics promote susceptibility to <i>C. difficile</i> infection through a CCR5-dependent immune response.

bioRxiv : the preprint server for biology·2026
Same author

CXCR3 ameliorates neutrophil-dependent disease severity in SARS-CoV-2 infection by regulating CD4<sup>+</sup> T cell recruitment.

Frontiers in immunology·2026
Same author

The hyaluronan receptor CD44 drives COVID-19 severity through its regulation of neutrophil migration.

PLoS pathogens·2026
Same author

REGULATION OF COLONIC MACROPHAGES AND TYPE-17 AND REGULATORY T CELLS IN DSS-COLITIS BY IBD-ASSOCIATED TRANSCRIPTION FACTOR, CREM.

bioRxiv : the preprint server for biology·2026
Same author

Human immune response to primary cryptosporidiosis parallels murine infection models.

Infection and immunity·2026
Same author

Non-study post-partum antibiotics use and risk of maternal and neonatal infection: A secondary analysis of the A-PLUS randomized controlled trial.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026

Related Experiment Video

Updated: Oct 23, 2025

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.8K

The IL-33-ILC2 pathway protects from amebic colitis.

Md Jashim Uddin1,2, Jhansi L Leslie1, Stacey L Burgess1

  • 1Department of Medicine: Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, VA, USA.

Mucosal Immunology
|August 17, 2021
PubMed
Summary

Interleukin-33 (IL-33) protects against Entamoeba histolytica infection by activating innate lymphoid cells (ILCs), specifically ILC2s, which are crucial for host defense in amebic colitis.

More Related Videos

Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens
10:59

Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens

Published on: May 12, 2019

10.0K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

17.0K

Related Experiment Videos

Last Updated: Oct 23, 2025

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

2.8K
Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens
10:59

Using Human Induced Pluripotent Stem Cell-derived Intestinal Organoids to Study and Modify Epithelial Cell Protection Against Salmonella and Other Pathogens

Published on: May 12, 2019

10.0K
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

17.0K

Area of Science:

  • Immunology
  • Parasitology
  • Molecular Biology

Background:

  • Entamoeba histolytica is a protozoan parasite causing intestinal and liver diseases.
  • Increased IL-33 mRNA expression is observed in the colon during E. histolytica infection.
  • IL-33 is a cytokine released upon cell injury, signaling tissue damage to the immune system.

Purpose of the Study:

  • To investigate the role of IL-33 in host defense against E. histolytica infection.
  • To elucidate the specific immune cells and pathways involved in IL-33-mediated protection.

Main Methods:

  • Transcriptomics analysis to assess gene expression changes during infection.
  • In vivo studies using mouse models treated with recombinant IL-33 or IL-33 signaling blockers.
  • Experiments with genetically modified mice (RAG2-/-, RAG2-/-γc-/-) and adoptive transfer of innate lymphoid cells (ILCs).

Main Results:

  • Recombinant IL-33 treatment protected mice from amebic infection and reduced intestinal damage.
  • Blocking IL-33 signaling increased susceptibility to amebiasis, with reduced IL-6 and inflammatory cell recruitment.
  • IL-33-mediated protection was dependent on innate lymphoid cells (ILCs), particularly ILC2s, and induced type 2 immune responses.

Conclusions:

  • The IL-33-ILC2 pathway is a critical host defense mechanism against amebic colitis.
  • IL-33 promotes resistance to Entamoeba histolytica infection by orchestrating ILC2-mediated immune responses.
  • ILC2s play a significant role in the natural resistance observed in certain mouse strains.